Cited by 49Growth Hormone and Insulin-like Growth FactorsPituitary Gland Disorders and TreatmentsHypothalamic control of reproductive hormones

Long-term safety and effectiveness of growth hormone therapy in Korean children with growth disorders: 5-year results of LG growth study

Open access
Rhie, Young-Jun, Yoo, Jae-Ho, Choi, Jin-Ho, Chae, Hyun-Wook, Kim, Jae Hyun, Chung, Sochung, Hwang, Il Tae, Shin, Choong Ho +2 more·2019·PLoS ONE

Abstract

PURPOSE: The aim of this registry study was to analyze the long-term safety and effectiveness of recombinant human growth hormone (rhGH) in South Korean pediatric patients (≥2 years of age) with growth hormone deficiency GHD) of idiopathic or organic etiology, idiopathic short stature, Turner syndrome, small for gestational age and chronic renal failure. METHODS: The study patients were followed-up till two years after the epiphyseal closure, with visits scheduled every six months. The outcome measures included the incidence of adverse events (AEs, in particular, neoplasia, glucose intolerance and hypothyroidism), as well as height standard deviation score (Ht SDS) and annual height velocity. The results of the interim analysis of a 5-year accumulated data for 2,024 patients (7,342 patient-years, PY) are presented. RESULTS: A total of 14 neoplasms were diagnosed (191/100,000 PY); 7 out of 9 malignancies were recurrent craniopharyngioma found in patients with organic GHD. Seven cases of glucose intolerance (95/100,000 PY) and 22 cases of hypothyroidism (300/100,000 PY) were detected; about half of the cases (4 and 10 cases each) were considered to be related with rhGH treatment. Most of the growth-retarded patients showed continuous improvement in Ht SDS, with the most prominent effect observed within a year of treatment initiation. The beneficial effect of rhGH on Ht SDS gain was maintained for 2-4 years. CONCLUSIONS: The incidence of AEs of interest in rhGH-treated patients was low, and most of the neoplasms were benign and/or non-related to rhGH. Most patients benefited from the therapy in terms of height increment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0216927

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rhie, Y.-J., Yoo, J.-H., Choi, J.-H., Chae, H.-W., Kim, J. H., Chung, S., Hwang, I. T., Shin, C. H., Kim, E. Y., & Kim, H.-S.
Affiliations
  • Korea University (KR)
  • Dong-A University (KR)
  • Asan Medical Center (KR)
  • Yonsei University (KR)
  • Seoul National University (KR)
  • Konkuk University (KR)
  • Hallym University (KR)
  • LG Chem (South Korea) (KR)
Corresponding author
Kim, Ho-Seong
Venue
PLoS ONE
Published
2019-05-16
Volume
14
Issue
5
Pages
e0216927
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2946348977
Cited by
49
References
32
Citations by year
2026: 8 · 2025: 6 · 2024: 6 · 2023: 3 · 2022: 12 · 2021: 11 · 2020: 1 · 2019: 2
FWCI
5.27
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
Funders
  • Chonbuk National University
  • Chonnam National University
  • Chosun University
  • Chungbuk National University
  • Chungnam National University
  • Kangwon National University
  • Keimyung University
  • Konyang University
  • Kyungpook National University
  • Soonchunhyang University
  • Ewha Womans University
  • Hallym University
  • Sungkyunkwan University
  • Catholic University of Korea
  • Catholic Kwandong University
  • CHA University
  • LG Chem
  • Samsung
  • Seoul St. Mary's Hospital, Catholic University of Korea
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
recombinant human growth hormone, growth hormone therapy, growth hormone deficiency, idiopathic short stature, Turner syndrome, small for gestational age, chronic kidney disease, long-term safety, adverse events, neoplasms, impaired glucose tolerance, hypothyroidism, height standard deviation score, height velocity, Korean children
MeSH terms
Adolescent, Blood Glucose, Body Height, Child, Child, Preschool, Female, Follow-Up Studies, Growth Disorders, Glycated Hemoglobin, Humans, Infant, Small for Gestational Age, Insulin-Like Growth Factor I, Kidney Failure, Chronic, Male, Neoplasms, Recombinant Proteins, Registries, Thyrotropin, Thyroxine, Turner Syndrome, Insulin-Like Growth Factor Binding Protein 3, Human Growth Hormone, Young Adult, Republic of Korea, Patient Safety

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review